IP Library Granted Patent US 8,440,735
Granted Patent B2
US 8,440,735 · App. 12/834,998 · Granted May 14, 2013

Method for making contact lenses

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,440,735
App. No.
12/834,998
Granted
May 14, 2013
Kind
B2
Abstract

The instant invention pertains to a method and a fluid composition for producing contact lenses with improved lens quality and with increased product yield. The method of the invention involves adding a phospholipid into a fluid composition including a lens-forming material in an amount sufficient to reduce an averaged mold separation force by at least about 40% in comparison with that without the phospholipids.

Claims (12)

1. A fluid composition for making contact lenses, comprising: a lens-forming material and a PEG-ylated phosphatidyl ethanolamines, wherein the lens-forming material is crosslinkable and/or polymerizable by actinic radiation in a mold to form a contact lens having a polymer matrix, wherein the PEG-ylated phosphatidyl ethanolamines migrates to the interface between the mold and the fluid composition therein to form an intact interfacial film within a desired time period and with a thickness sufficient to reduce averaged mold separation force, wherein the PEG-ylated phosphatidyl ethanolamines is present in an amount sufficient to reduce an averaged mold separation force by at least about 40% in comparison with that without the phospholipids.

2. The fluid composition of claim 1 , where the PEG-ylated phosphatidyl ethanolamines is at least one member selected from the group consisting of PEG-ylated dipalmitoyl phosphatidylethanolamine (DPPE-PEG), PEG-ylated palmitoyloleoyl phosphatidylethanolamine (POPE-PEG), PEG-ylated dioleoyl phosphatidylethanolamine (DOPE-PEG) and PEG-ylated distearoyl phosphatidylethanolamine (DSPE-PEG).

3. The fluid composition of claim 2 , where the PEG-ylated phosphatidyl ethanolamines is PEG-ylated distearoyl phosphatidylethanolamine (DSPE-PEG).

4. The fluid composition of claim 1 , wherein the fluid composition comprises from 0.5% to 10% PEG-ylated phosphatidyl ethanolamines.

5. The fluid composition of claim 4 , wherein the fluid composition comprises from 1.0% to 6.0% PEG-ylated phosphatidyl ethanolamines.

6. The fluid composition of claim 5 , wherein the fluid composition comprises from 1.5% to 4.0% PEG-ylated phosphatidyl ethanolamines.

7. The fluid composition of claim 1 , wherein the lens-forming material comprises at least one prepolymer.

8. The fluid composition of claim 7 , wherein the lens-forming material comprises at least one prepolymer with two or more thiol groups or with two or more ene-containing groups.

9. The fluid composition of claim 7 , wherein the prepolymer is a silicone-containing prepolymer or a silicone-free prepolymer.

10. The fluid composition of claim 7 , wherein the prepolymer is a water-soluble silicone-free prepolymer.

11. The fluid composition of claim 9 , wherein the silicone-containing prepolymer is capable of forming, in the absence of any monomer and/or crosslinking agent, a silicone hydrogel contact lens which has at least one property selected from the group consisting of an apparent oxygen permeability of at least 40 barrers, an Ionoflux Diffusion Coefficient, D, of greater than about 1.5.times.10.sup.−6 mm.sup.2/min, an elastic modulus of from about 0.2 MPa to about 2.0 MPa, and a water content of from about 15% to about 80% by weight when fully hydrated.

12. The fluid composition of claim 1 , wherein the fluid composition comprises at least one components selected from the group consisting of a polymerization initiator, a visibility tinting agent, a UV-blocking (absorbing) agent, a photosensitizer, an antimicrobial agent, a bioactive agent, a mold releasing agent, and a leachable lubricant.

Assignments (2)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2010
From: PRUITT, JOHN DALLAS; WINTERTON, LYNN COOK; SEIFERLING, BERNHARD; VOGT, JUERGEN; BOTHE, HARALD
To: NOVARTIS AG
Reel/Frame 024674/0729 →